| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
3 companies
Nancy T Chang is Director at IMMX and has filed Form 4s across 3 companies. Nancy T Chang's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.9M at current prices.
The biggest single holding is IMMX (~$3.3M) as Director.
Nancy T Chang has 10 Form 4 filings on record from July 2023 to July 2026, across 3 companies: Director at W&T Offshore (WTI), 2023–2026; Director at Immix Biopharma (IMMX), 2025–2026; Director, 10% Owner at Galera Therapeutics (GRTX), 2024–2026.
The 17 reported transactions were 8 option or other derivative awards, 3 option exercises, 2 dispositions back to the company and 1 open-market sale, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $500K and 1 sale worth about $199K.
The only open-market purchase was 7,644,932 shares of GRTX at an average $0.07 on December 30, 2024, about $500K.
The only open-market sale was 60,000 shares of WTI at an average $3.31 on July 15, 2026, about $199K.